Logo - springer
Slogan - springer

Medicine - Oncology & Hematology | Cancer Clinical Trials: Proactive Strategies

Cancer Clinical Trials: Proactive Strategies

Series: Cancer Treatment and Research, Vol. 132

Leong, Stanley P. L. (Ed.)

2007, XX, 320 p.

Available Formats:
eBook
Information

Springer eBooks may be purchased by end-customers only and are sold without copy protection (DRM free). Instead, all eBooks include personalized watermarks. This means you can read the Springer eBooks across numerous devices such as Laptops, eReaders, and tablets.

You can pay for Springer eBooks with Visa, Mastercard, American Express or Paypal.

After the purchase you can directly download the eBook file or read it online in our Springer eBook Reader. Furthermore your eBook will be stored in your MySpringer account. So you can always re-download your eBooks.

 
$159.00

(net) price for USA

ISBN 978-0-387-33225-3

digitally watermarked, no DRM

Included Format: PDF

download immediately after purchase


learn more about Springer eBooks

add to marked items

Hardcover
Information

Hardcover version

You can pay for Springer Books with Visa, Mastercard, American Express or Paypal.

Standard shipping is free of charge for individual customers.

 
$209.00

(net) price for USA

ISBN 978-0-387-33224-6

free shipping for individuals worldwide

usually dispatched within 3 to 5 business days


add to marked items

Foreword written by Samuel A. Wells, Jr., MD
Professor of Surgery
Duke University Medical Center, Durham, NC

According to the American Cancer Society, about 1 million persons in the United States will be diagnosed with solid cancer every year. About 50% of them will be potentially cured by surgery. The other half of the population may develop metastatic cancer. To date, there is no systemic treatment available to cure metastatic cancer. Therefore, cancer clinical trials are critical to evaluate reliable treatment modalities against metastatic cancer. Likewise, adjuvant trials are needed to prevent high risk patients from developing recurrence following definitive surgical resection of their cancer. Only about 3-5% of the adult cancer patients are enrolled in clinical trials. When the pediatric cancer clinical trial groups were able to accrue over 40 percent of eligible patients to their clinical trials, significant impact was made on the survival of these pediatric cancer patients. However, multiple barriers exist to block adult cancer patients from entering into clinical protocols. The ever-changing regulations for clinical trials and the ethical dilemma of treating cancer patients as subjects have made it ever so difficult for the principal investigators to conduct clinical research, especially when they are often ill-informed of the complex nature of the regulations and over-worked. Therefore, cancer clinical trials are at a critical junction. The objective of this book is to bring the issues of cancer clinical trials into focus so that proactive strategies may be developed to make such trials more user-friendly. Ultimately, the cancer patients will be benefited.

"Clinical trials remain the most important vehicle for improving the care of cancer patients. This text presents the fundamental components and challenges involving clinical investigations. Leading experts discuss the critical issues covering the spectrum of important topics from planning to application."

Steven T. Rosen, M.D.
Series Editor

Content Level » Professional/practitioner

Keywords » breast cancer - cancer - cancer research - cancer therapy - clinical trial - oncology - surgery

Related subjects » Oncology & Hematology

Table of contents / Sample pages 

Historical Perspective and Evolving Concerns for Human Research.- Cancer Trials and the Institutional Review Board (IRB).- NCI’s Cancer Therapy Evaluation Program: A Commitment to Treatment Trials.- The Role of the FDA in Cancer Clinical Trials.- The Role of Cooperative Groups in Cancer Clinical Trials.- The Advocate Role in Clinical Study Development and Partnering with Patient Advocates in Your Local Institution.- The National Breast Cancer Coalition: Setting the Standard for Advocate Collaboration in Clinical Trials.- The Role of the Principal Investigator in Cancer Clinical Trials.- The Audit Process and How to Ensure a Successful Audit.- The Privacy Rule (HIPAA) as it Relates to Clinical Research.- The Commission on Cancer, American College of Surgeons’ Response to HIPAA.- Ethical and Legal Issues in the Conduct of Cancer Clinical Trials.- The Role of the Office of Research Integrity in Cancer Clinical Trials.- Strategies for the Administration of a Clinical Trials Infrastructure: Lessons from a Comprehensive Cancer Center.- The Clinical Research Process: Building a System in Harmony with its Users.- Cancer Research and Clinical Trial in Action: An Important Exercise Before You Embark on Your Study.

Popular Content within this publication 

 

Articles

Read this Book on Springerlink

Services for this book

New Book Alert

Get alerted on new Springer publications in the subject area of Oncology.